Kyntra Bio, Inc. (NASDAQ:KYNB) Q1 2026 Earnings Call Transcript May 11, 2026
Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.
Operator: Good day, and thank you for standing by. Welcome to the Kyntra Bio’s First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today’s call is being recorded. I would now like to hand it over to our first speaker, Gaia Shamis. Please go ahead.
Daia Vasiliver-Shamis:...
